The MSIDE ML algorithm detected a patient cohort:
- PIK3CA gene mutation
- Therapy with a combination of 3 drugs:
- Paclitaxel
- Doxorubicin
- Cyclophosphamide
shows a survival rate of 5 years at 100% which is superior to other drug combinations.
Data source: GDC, 2017 (proprietary MSIDE ML algorithm)